myocardial infarction
RESULTS: In the       absence of streptokinase resistance, streptokinase is a cost effective strategy       for patients with suspected myocardial infarction, even when the expected       mortality is low.
RESULTS: In the       absence of streptokinase resistance, streptokinase is a cost effective strategy       for  @OBJECT$   @PREDICAT$  suspected  @SUBJECT$ , even when the expected       mortality is low.